Background: Antiphospholipid syndrome (APS) is defined by arterial, venous, or
microvascular thrombosis or obstetric morbidity together with confirmed positive test results …

Background Recent studies demonstrate that prothrombotic antiphospholipid antibodies
(aPL) are overrepresented in patients with myocardial infarction (MI) due to coronary artery …

A 39-year-old man with a history of ischemic stroke 10 years ago presented after 1 day of
right calf swelling and shortness of breath. He reported no trauma, surgery, recent prolonged …

To Editor: Dr Levine and colleagues1 found that the presence of antiphospholipid antibodies
(aPL) among patients with ischemic stroke did not predict an increased risk for subsequent …

As recently written by Cruz and coll., antiphospholipid antibodies (aPL) are frequently found
in immune thrombocytopenia (ITP) and are not associated with specific clinical feature [1] …

Objective: To determine if the presence of antiphospholipid antibody (aPL) in healthy
pregnant women is associated with adverse pregnancy outcome, including 1) intrauterine …

BACKGROUND: Antiphospholipid antibodies, the hallmark of the antiphospholipid
syndrome, are associated with both venous and arterial thrombosis. Despite some reports …

Antiphospholipid antibodies (aPL) have been implicated in the pathogenesis of coronary
artery disease (CAD). We evaluated the presence of aPL in patients with chest pain/acute …

The diagnosis of antiphospholipid syndrome is predominantly made in the laboratory and
depends on the persistent presence of antiphospholipid antibodies in individuals with …

Objectives Anti-β2 glycoprotein I domain I (anti-domain I) and anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies are present in patients with antiphospholipid syndrome …